Home > Events > Meet veristat at the ic life science and healthcare innovation summit

1 min read

Meet Veristat at the iC³ Life Science and Healthcare Innovation Summit

Where Life Science Innovation Moves Forward

iC³ Life Science and Healthcare Innovation Summit:

September 24-25, 2026 - Arlington, TX

Veristat is pleased to attend the 2026 iC³ Life Science & Healthcare Innovation Summit, where leaders from across life sciences, healthcare, research, and investment come together to explore the ideas and opportunities shaping the industry’s future. The summit creates an important forum for connecting scientific innovation with the expertise and resources needed to move promising therapies forward.

We’re looking forward to connecting with innovators and development teams to discuss the opportunities and challenges shaping their programs. Veristat brings integrated expertise across regulatory strategy, clinical development, biometrics, and medical writing to help teams make informed decisions, navigate development complexity, and advance promising therapies toward patients.

Meet with Us
Connect with us at the event to explore how Veristat’s scientific leadership and focused capabilities can help advance your clinical and regulatory milestones.
Caroline Hyde, Business Development Manager

Schedule a Meeting in Advance
Complete the form on this page to reserve time with our team. We welcome the opportunity to learn about your upcoming programs and explore how Veristat can support your development strategy. 

Our Expertise
Whether you're launching a first-in-human study or navigating complex regulatory pathways, Veristat delivers integrated expertise and personalized support across the development lifecycle:

  • Clinical Operations Excellence
  • Global Regulatory Strategy & Submissions
  • Full-Service Clinical Development Solutions

If you’ll be at the meeting, let’s make time to discuss how we can help move your programs forward.

 

Share This Event:

   

8 min read

Monthly FDA Guidance and Regulatory News Review - July 2026

This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...

1 min read

Scope of Things Podcast: Daphne Smyth on the Chinese Drug Development Market Expansion

China is rapidly becoming one of the most influential forces in global drug development—but bringing innovative...